Quantification of doxazosin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry.

Hydrophilic interaction LC with MS/MS (HILIC-MS/MS) was described as a rapid, sensitive, and selective method for the quantification of doxazosin in human plasma. Doxazosin and cisapride (internal standard) were extracted from human plasma with ethyl acetate at alkaline pH and analyzed on an Atlantis HILIC Silica column with the mobile phase of ACN/ammonium formate (100 mM, pH 4.5) (93:7 v/v). The analytes were detected using an ESI MS/MS in the selective-reaction-monitoring mode. The standard curve was linear (r = 0.9994) over the concentration range of 0.2-50 ng/mL. The LOQ for doxazosin was 0.2 ng/mL using 100 microL plasma sample. The CV and relative error for intra- and interassay at four QC levels were 3.7-8.7% and 0.0-9.8%, respectively. The matrix effect for doxazosin and cisapride were practically absent. The recoveries of doxazosin and cisapride were 67.4 and 61.7%, respectively. This method was successfully applied to the pharmacokinetic study of doxazosin in humans.

[1]  Junfa Yin,et al.  On-line solid-phase extraction with a monolithic weak cation-exchange column and simultaneous screening of alpha1-adrenergic receptor antagonists in human plasma. , 2007, Journal of separation science.

[2]  Yong-Bok Lee,et al.  Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of levosulpiride in human plasma. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  P. Meredith,et al.  Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation. , 1999, British Journal of Clinical Pharmacology.

[4]  Kang-Choon Lee,et al.  Determination of gabapentin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.

[5]  B. Olsen Hydrophilic interaction chromatography using amino and silica columns for the determination of polar pharmaceuticals and impurities. , 2001, Journal of chromatography. A.

[6]  A. Saraphanchotiwitthaya,et al.  Validation and pharmacokinetic application of a method for determination of doxazosin in human plasma by high-performance liquid chromatography. , 2006, Biomedical chromatography : BMC.

[7]  T. Twomey,et al.  Liquid chromatographic analysis of doxazosin in human serum with manual and robotic sample preparation. , 1988, Journal of chromatographic science.

[8]  O. Al-Dirbashi,et al.  UPLC-MS/MS determination of doxazosine in human plasma , 2006, Analytical and bioanalytical chemistry.

[9]  E. Crawford,et al.  Terazosin, doxazosin, and prazosin: current clinical experience. , 2001, Urology.

[10]  D. McCalley,et al.  Is hydrophilic interaction chromatography with silica columns a viable alternative to reversed-phase liquid chromatography for the analysis of ionisable compounds? , 2007, Journal of chromatography. A.

[11]  Knut Irgum,et al.  Hydrophilic interaction chromatography. , 2006, Journal of separation science.

[12]  H. Gwak,et al.  Pharmacokinetics of Doxazosin Gastrointestinal Therapeutic System after Multiple Administration in Korean Healthy Volunteers , 2007, Drug development and industrial pharmacy.

[13]  Y. Youn,et al.  Analysis of carvedilol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry. , 2007, Journal of pharmaceutical and biomedical analysis.

[14]  A. Saraphanchotiwitthaya,et al.  Improvement of doxazosin determination in human plasma using high-performance liquid chromatography with fluorescence detection. , 2005, Journal of chromatographic science.

[15]  W. Naidong,et al.  Bioanalytical liquid chromatography tandem mass spectrometry methods on underivatized silica columns with aqueous/organic mobile phases. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  Huande Li,et al.  LC-MS determination and relative bioavailability of doxazosin mesylate tablets in healthy Chinese male volunteers. , 2007, Journal of pharmaceutical and biomedical analysis.

[17]  H. Lepor,et al.  α1-Adrenoceptor selectivity and the treatment of benign prostatic hyperplasia and lower urinary tract symptoms , 2000, Prostate Cancer and Prostatic Diseases.

[18]  Y. Choi,et al.  High-performance liquid chromatographic determination of doxazosin in human plasma for bioequivalence study of controlled release doxazosin tablets. , 2006, Biomedical chromatography : BMC.

[19]  W. Shou,et al.  Liquid/liquid extraction using 96-well plate format in conjunction with hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the analysis of fluconazole in human plasma. , 2003, Journal of pharmaceutical and biomedical analysis.

[20]  G. Jackman,et al.  Validation of a solid-phase extraction high-performance liquid chromatographic assay for doxazosin. , 1991, Journal of chromatography.